Women's health. The vanishing promises of hormone replacement.
Martin
M
Enserink
D001943:Breast Neoplasms / Q000453:epidemiology*; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000627:therapeutic use; D008593:Menopause; D017698:Postmenopause; D011655:Pulmonary Embolism / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015983:Selection Bias; D013997:Time Factors
D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate